Publications (link to AU profile)
The role of macrophages in inflammation and cancer focus on two main topics:
- Biomarker discovery development, validation and use of macrophage biomarkers in disease.
- Targeted therapy. Specific targeting of drugs to macrophages for antiinflammatory or immunomodulating effects.
Keywords: assay validation, CD163, CD206, SIRPα, Multiplex, ELISA, Flowcytometry, Nanosight, LCMS, Automation, ddPCR, myeloma, cancer, inflammation, polarisation, immunotherapy, checkpoints, microenvironment, Vitamin D.
Kristian Wiborg Antonsen
Targeted inhibition of phagocytosis checkpoints in tumor-associated macrophages
Started 08.2020
Financed by Danish Cancer Society
Co-supervisors: Søren K. Moestrup, Anders Etzerodt, Boe Sandahl Sørensen
Vitamin D and Alveolar Macrophages in Idiopathic Pulmonary Fibrosis
Started 02.2021
Financed by Aarhus University and Frimodt-Heineke Fonden
Co-supervisors: Elisabeth Bendstrup, Rie Harboe Nygaard, Søren K. Moestrup
Henriette Nymark Friis
Macrophage "don't eat me" checkpoints as biomarkers to monitor immunotherapy in bladder cancer
Started 09.2023
Financed by the Independent Research Fund Denmark, Danish Cancer Research Fund and Thora og Viggo Groves Mindelegat
Co-supervisors: Torben Steiniche, Molly Ingersoll, Lars Dyskjøt Andersen